| BioVision |
2411-1 |
24(S)-Hydroxycholesterol
|
1 mg |
|
|
| BioVision |
2409-1 |
EZSolution™ 3-Deazaneplanocin A
|
1 mg |
|
|
| BioVision |
2410-5 |
HPI-1
|
5 mg |
|
|
| BioVision |
2408-1000 |
L-Selenomethionine
|
1 g |
|
|
| BioVision |
2407-1 |
(+)-Blebbistatin
|
1 mg |
|
|
| BioVision |
2407-5 |
(+)-Blebbistatin
|
5 mg |
|
|
| BioVision |
2408-100 |
L-Selenomethionine
|
100 mg |
|
|
| BioVision |
2408-500 |
L-Selenomethionine
|
500 mg |
|
|
| BioVision |
2406-1 |
(-)-Blebbistatin
|
1 mg |
|
|
| BioVision |
2406-5 |
(-)-Blebbistatin
|
5 mg |
|
|
| BioVision |
2404-5 |
AKR1C3 Inhibitor II
|
5 mg |
|
|
| BioVision |
2404-25 |
AKR1C3 Inhibitor II
|
25 mg |
|
|
| BioVision |
2405-5 |
(±)-Blebbistatin
|
5 mg |
|
|
| BioVision |
2405-25 |
(±)-Blebbistatin
|
25 mg |
|
|
| BioVision |
2403-25 |
AKR1C3 Inhibitor I
|
25 mg |
|
|
| BioVision |
2400-5 |
GSK-3787
|
5 mg |
|
|
| BioVision |
2400-25 |
GSK-3787
|
25 mg |
|
|
| BioVision |
2403-5 |
AKR1C3 Inhibitor I
|
5 mg |
|
|
| BioVision |
2399-10 |
Felodipine
|
10 mg |
|
|
| BioVision |
2399-50 |
Felodipine
|
50 mg |
|
|
| BioVision |
2398-25 |
FCCP
|
25 mg |
|
|
| BioVision |
2398-5 |
FCCP
|
5 mg |
|
|
| BioVision |
2395-25 |
HDAC Substrate II, Colorimetric
|
5 mg |
|
|
| BioVision |
2396-5 |
HDAC Substrate, Fluorogenic
|
5 mg |
|
|
| BioVision |
2396-25 |
HDAC Substrate, Fluorogenic
|
25 mg |
|
|
| BioVision |
2397-5 |
Epalrestat
|
5 mg |
|
|
| BioVision |
2397-25 |
Epalrestat
|
25 mg |
|
|
| BioVision |
2395-5 |
HDAC Substrate II, Colorimetric
|
5 mg |
|
|
| BioVision |
2394-50 |
CENTA β-lactamase substrate
|
50 mg |
|
|
| BioVision |
2394-10 |
CENTA β-lactamase substrate
|
10 mg |
|
|
| BioVision |
2391-5 |
C2-Dihydroceramide
|
5 mg |
|
|
| BioVision |
2391-25 |
C2-Dihydroceramide
|
25 mg |
|
|
| BioVision |
2392-5 |
MMP-13 inhibitor
|
5 mg |
|
|
| BioVision |
2392-25 |
MMP-13 inhibitor
|
25 mg |
|
|
| BioVision |
2393-5 |
Cilostazol
|
5 mg |
|
|
| BioVision |
2393-25 |
Cilostazol
|
25 mg |
|
|
| BioVision |
2390-25 |
C2 Ceramide
|
25 mg |
|
|
| BioVision |
2389-250 |
Andrographolide
|
250 mg |
|
|
| BioVision |
2390-5 |
C2 Ceramide
|
5 mg |
|
|
| BioVision |
2388-25 |
Nitrocefin
|
25 mg |
|
|
| BioVision |
2389-50 |
Andrographolide
|
50 mg |
|
|
| BioVision |
2387-50 |
2'-Deoxy-5-fluorocytidine
|
50 mg |
|
|
| BioVision |
2387-250 |
2'-Deoxy-5-fluorocytidine
|
250 mg |
|
|
| BioVision |
2388-5 |
Nitrocefin
|
5 mg |
|
|
| BioVision |
2386-25 |
Oprozomib
|
25 mg |
|
|
| BioVision |
2385-5 |
Carfilzomib
|
5 mg |
|
|
| BioVision |
2385-25 |
Carfilzomib
|
25 mg |
|
|
| BioVision |
2386-5 |
Oprozomib
|
5 mg |
|
|
| BioVision |
2383-25 |
EPZ-6438
|
25 mg |
|
|
| BioVision |
2384-1 |
(-)-JQ1
|
1 mg |
|
|